After a federal judge threw out the government’s first indictment of former GlaxoSmithKline PLC in-house lawyer Lauren Stevens because of improper jury instructions, Reid Weingarten refused to take a breather. When the government obtained a second indictment less than one month later, he pushed for a quick trial. Her court date would happen in a matter of weeks, not months.
The gambit paid off. After the government rested its case, U.S. District Judge Roger Titus entered a rare directed verdict acquitting Stevens of six criminal charges involving her alleged obstruction of a U.S. Food and Drug Administration investigation of Glaxo’s off-label marketing of the anti-depression drug Wellbutrin. The government claimed that Stevens helped try to hide evidence that doctors paid by Glaxo promoted the drug’s use for unauthorized conditions, including obesity.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
